TEST BANK cn
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
cn cn cn cn cn cn cn
Author: Teri Moser Woo and Wendy L. Wright
cn cn cn cn cn cn cn
, TABLE OF CONTENTcn cn
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ...................................................................... 4
cn cn cn cn cn cn cn cn cn cn
Chapter 2. Review of Basic Principles of Pharmacology ...................................................................................... 5
cn cn cn cn cn cn cn
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
cn cn cn cn
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
cn cn cn cn cn cn cn
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
cn cn cn cn
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
cn cn cn cn cn
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
cn cn cn cn
Chapter 8. Herbal Therapies ................................................................................................................................ 28
cn cn cn
Chapter 9. Cannabis ............................................................................................................................................ 31
cn cn
Chapter 10. Pharmacoeconomics......................................................................................................................... 35
cn cn
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
cn cn cn cn cn cn cn
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................. 45
cn cn cn cn cn cn cn
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
cn cn cn cn cn cn cn cn
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
cn cn cn cn cn cn
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
cn cn cn cn cn cn
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
cn cn cn cn cn cn cn cn cn
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
cn cn cn cn cn cn cn
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
cn cn cn cn cn cn
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
cn cn cn cn cn cn cn cn cn cn cn
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................. 83
cn cn cn cn cn cn cn cn cn cn cn
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
cn cn cn cn cn cn
Chapter 22. Drugs Affecting the Bones and Joints.............................................................................................. 92
cn cn cn cn cn cn cn
Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
cn cn cn cn cn cn
Chapter 24. Drugs Used to Treat Bacterial Infections ....................................................................................... 101
cn cn cn cn cn cn cn
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................ 105
cn cn cn cn cn cn cn cn cn cn
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................ 108
cn cn cn cn cn cn cn
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
cn cn cn cn cn cn cn cn cn
Chapter 28. Anemia........................................................................................................................................... 113
cn cn
Chapter 29. Anxiety and Depression ................................................................................................................. 116
cn cn cn cn
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
cn cn cn cn
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
cn cn cn cn
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
cn cn cn cn cn
Chapter 33. Contraception ................................................................................................................................. 127
cn cn
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
cn cn cn cn cn
Chapter 35. Dermatological Conditions ............................................................................................................ 134
cn cn cn
Chapter 36. Diabetes Management.................................................................................................................... 138
cn cn cn
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
cn cn cn cn cn cn cn
Chapter 38. Headaches ...................................................................................................................................... 149
cn cn
Chapter 39. Heart Failure .................................................................................................................................. 153
cn cn cn
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
cn cn cn cn cn cn cn
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
cn cn cn cn
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
cn cn
Chapter 43. Hypertension .................................................................................................................................. 169
cn cn
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
cn cn cn cn
Chapter 45. Obesity ........................................................................................................................................... 177
cn cn
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
cn cn cn cn cn cn cn
Chapter 47. Pneumonia ..................................................................................................................................... 185
cn cn
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
cn cn cn cn cn cn
Chapter 49. Substance Use Disorders................................................................................................................ 190
cn cn cn cn
Chapter 50. Tuberculosis ................................................................................................................................... 195
cn cn
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ........... 197
cn cn cn cn cn cn cn cn cn cn cn cn
Chapter 52. Urinary Tract Infections ................................................................................................................. 200
cn cn cn cn
Chapter 53. Women as Patients ......................................................................................................................... 203
cn cn cn cn
Chapter 54. Men as Patients .............................................................................................................................. 207
cn cn cn cn
Chapter 55. Pediatric Patients ............................................................................................................................ 209
cn cn cn
Chapter 57. Geriatric Patients............................................................................................................................ 213
cn cn cn
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e cn cn cn cn Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
cn cn cn cn cn cn cn cn cn cn
MULTIPLE CHOICE cn
1. Nurse practitioner prescriptive authority is regulated by:
cn cn cn cn cn cn
A. The National Council of State Boards of Nursing
cn cn cn cn cn cn cn
B. The U.S. Drug Enforcement Administration
cn cn cn cn
C. The State Board of Nursing for each state
cn cn cn cn cn cn cn
D. The State Board of Pharmacy cn cn cn cn
ANS: C c n PTS: c n c n 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber i
cn cn cn cn cn cn cn cn cn cn cn cn cn cn
nclude:
A. Nurses know more about pharmacology than other prescribers because they take it b
cn cn cn cn cn cn cn cn cn cn cn cn
oth in their basic nursing program and in their APRN program.
cn cn cn cn cn cn cn cn cn cn
B. Nurses care for the patient from a holistic approach and include the patient in d
cn cn cn cn cn cn cn cn cn cn cn cn cn cn
ecision-making regarding their care. cn cn cn
C. APRNs are less likely to prescribe narcotics and other controlled substances.
cn cn cn cn cn cn cn cn cn cn
D. APRNs are able to prescribe independently in all states, whereas a physician’s a
cn cn cn cn cn cn cn cn cn cn cn cn
ssistant needs to have a physician supervising their practice.
cn cn cn cn cn cn cn cn
ANS: B c n PTS: c n c n 1
3. Clinical judgment in prescribing includes:
cn cn cn cn
A. Factoring in the cost to the patient of the medication prescribed
cn cn cn cn cn cn cn cn cn cn
B. Always prescribing the newest medication available for the disease process
cn cn cn cn cn cn cn cn cn
C. Handing out drug samples to poor patients cn cn cn cn cn cn
D. Prescribing all generic medications to cut costs cn cn cn cn cn cn
ANS: A c n PTS: c n c n 1
4. The process for choosing an effective drug for a disorder includes:
cn cn cn cn cn cn cn cn cn cn
A. Asking the patient what drug they think would work best for them
cn cn cn cn cn cn cn cn cn cn cn
B. Consulting nationally recognized guidelines for disease management cn cn cn cn cn cn
C. Prescribing medications that are available as samples before writing a prescription
cn cn cn cn cn cn cn cn cn cn
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
cn cn cn cn cn cn cn
ANS: B c n PTS: c n c n 1
5. Nonintentional nonadherence of drug therapy may occur due to: cn cn cn cn cn cn cn cn
A. Belief that medication does not work
cn cn cn cn cn
B. Adverse drug reactions cn cn
C. Chronic conditions that require daily therapycn cn cn cn cn
D. Forgetfulness or distraction cn cn
ANS: D c n PTS: c n c n 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
cn cn cn cn cn cn cn
Author: Teri Moser Woo and Wendy L. Wright
cn cn cn cn cn cn cn
, TABLE OF CONTENTcn cn
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ...................................................................... 4
cn cn cn cn cn cn cn cn cn cn
Chapter 2. Review of Basic Principles of Pharmacology ...................................................................................... 5
cn cn cn cn cn cn cn
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
cn cn cn cn
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
cn cn cn cn cn cn cn
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
cn cn cn cn
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
cn cn cn cn cn
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
cn cn cn cn
Chapter 8. Herbal Therapies ................................................................................................................................ 28
cn cn cn
Chapter 9. Cannabis ............................................................................................................................................ 31
cn cn
Chapter 10. Pharmacoeconomics......................................................................................................................... 35
cn cn
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
cn cn cn cn cn cn cn
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................. 45
cn cn cn cn cn cn cn
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
cn cn cn cn cn cn cn cn
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
cn cn cn cn cn cn
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
cn cn cn cn cn cn
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
cn cn cn cn cn cn cn cn cn
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
cn cn cn cn cn cn cn
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
cn cn cn cn cn cn
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
cn cn cn cn cn cn cn cn cn cn cn
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................. 83
cn cn cn cn cn cn cn cn cn cn cn
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
cn cn cn cn cn cn
Chapter 22. Drugs Affecting the Bones and Joints.............................................................................................. 92
cn cn cn cn cn cn cn
Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
cn cn cn cn cn cn
Chapter 24. Drugs Used to Treat Bacterial Infections ....................................................................................... 101
cn cn cn cn cn cn cn
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................ 105
cn cn cn cn cn cn cn cn cn cn
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................ 108
cn cn cn cn cn cn cn
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
cn cn cn cn cn cn cn cn cn
Chapter 28. Anemia........................................................................................................................................... 113
cn cn
Chapter 29. Anxiety and Depression ................................................................................................................. 116
cn cn cn cn
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
cn cn cn cn
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
cn cn cn cn
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
cn cn cn cn cn
Chapter 33. Contraception ................................................................................................................................. 127
cn cn
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
cn cn cn cn cn
Chapter 35. Dermatological Conditions ............................................................................................................ 134
cn cn cn
Chapter 36. Diabetes Management.................................................................................................................... 138
cn cn cn
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
cn cn cn cn cn cn cn
Chapter 38. Headaches ...................................................................................................................................... 149
cn cn
Chapter 39. Heart Failure .................................................................................................................................. 153
cn cn cn
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
cn cn cn cn cn cn cn
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
cn cn cn cn
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
cn cn
Chapter 43. Hypertension .................................................................................................................................. 169
cn cn
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
cn cn cn cn
Chapter 45. Obesity ........................................................................................................................................... 177
cn cn
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
cn cn cn cn cn cn cn
Chapter 47. Pneumonia ..................................................................................................................................... 185
cn cn
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
cn cn cn cn cn cn
Chapter 49. Substance Use Disorders................................................................................................................ 190
cn cn cn cn
Chapter 50. Tuberculosis ................................................................................................................................... 195
cn cn
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ........... 197
cn cn cn cn cn cn cn cn cn cn cn cn
Chapter 52. Urinary Tract Infections ................................................................................................................. 200
cn cn cn cn
Chapter 53. Women as Patients ......................................................................................................................... 203
cn cn cn cn
Chapter 54. Men as Patients .............................................................................................................................. 207
cn cn cn cn
Chapter 55. Pediatric Patients ............................................................................................................................ 209
cn cn cn
Chapter 57. Geriatric Patients............................................................................................................................ 213
cn cn cn
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e cn cn cn cn Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
cn cn cn cn cn cn cn cn cn cn
MULTIPLE CHOICE cn
1. Nurse practitioner prescriptive authority is regulated by:
cn cn cn cn cn cn
A. The National Council of State Boards of Nursing
cn cn cn cn cn cn cn
B. The U.S. Drug Enforcement Administration
cn cn cn cn
C. The State Board of Nursing for each state
cn cn cn cn cn cn cn
D. The State Board of Pharmacy cn cn cn cn
ANS: C c n PTS: c n c n 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber i
cn cn cn cn cn cn cn cn cn cn cn cn cn cn
nclude:
A. Nurses know more about pharmacology than other prescribers because they take it b
cn cn cn cn cn cn cn cn cn cn cn cn
oth in their basic nursing program and in their APRN program.
cn cn cn cn cn cn cn cn cn cn
B. Nurses care for the patient from a holistic approach and include the patient in d
cn cn cn cn cn cn cn cn cn cn cn cn cn cn
ecision-making regarding their care. cn cn cn
C. APRNs are less likely to prescribe narcotics and other controlled substances.
cn cn cn cn cn cn cn cn cn cn
D. APRNs are able to prescribe independently in all states, whereas a physician’s a
cn cn cn cn cn cn cn cn cn cn cn cn
ssistant needs to have a physician supervising their practice.
cn cn cn cn cn cn cn cn
ANS: B c n PTS: c n c n 1
3. Clinical judgment in prescribing includes:
cn cn cn cn
A. Factoring in the cost to the patient of the medication prescribed
cn cn cn cn cn cn cn cn cn cn
B. Always prescribing the newest medication available for the disease process
cn cn cn cn cn cn cn cn cn
C. Handing out drug samples to poor patients cn cn cn cn cn cn
D. Prescribing all generic medications to cut costs cn cn cn cn cn cn
ANS: A c n PTS: c n c n 1
4. The process for choosing an effective drug for a disorder includes:
cn cn cn cn cn cn cn cn cn cn
A. Asking the patient what drug they think would work best for them
cn cn cn cn cn cn cn cn cn cn cn
B. Consulting nationally recognized guidelines for disease management cn cn cn cn cn cn
C. Prescribing medications that are available as samples before writing a prescription
cn cn cn cn cn cn cn cn cn cn
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
cn cn cn cn cn cn cn
ANS: B c n PTS: c n c n 1
5. Nonintentional nonadherence of drug therapy may occur due to: cn cn cn cn cn cn cn cn
A. Belief that medication does not work
cn cn cn cn cn
B. Adverse drug reactions cn cn
C. Chronic conditions that require daily therapycn cn cn cn cn
D. Forgetfulness or distraction cn cn
ANS: D c n PTS: c n c n 1
